IGM Biosciences, Inc.’s $230 Million Public Offering

Wilson Sonsini Goodrich & Rosati advised IGM Biosciences, Inc. on the deal. IGM Biosciences, Inc. announced the closing of its upsized underwritten public offering of 1,221,224…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here